Cargando…
Effect of the 3q26-coding oncogene SEC62 as a potential prognostic marker in patients with ovarian neoplasia
With approximately 220,000 newly diagnosed cases per year, ovarian cancer is among the most frequently occurring cancers among women and the second leading cause of death from gynecological malignancies worldwide. About 70% of these cancers are diagnosed in advanced stages (FIGO IIB–IV), with a 5-ye...
Autores principales: | Radosa, Julia C., Kasoha, Mariz, Schilz, Anne-Christine, Takacs, Zoltan F., Kaya, Askin, Radosa, Marc P., Linxweiler, Barbara, Linxweiler, Maximilian, Bohle, Rainer M., Wagner, Mathias, Wagenpfeil, Gudrun, Solomayer, Erich-Franz, Zimmermann, Julia S. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845558/ https://www.ncbi.nlm.nih.gov/pubmed/36685175 http://dx.doi.org/10.3389/fphys.2022.1054508 |
Ejemplares similares
-
The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer
por: Radosa, Julia C., et al.
Publicado: (2023) -
The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors
por: Zimmermann, Julia S. M., et al.
Publicado: (2022) -
Comparison of Maternal Serum Levels and Placental mRNA Levels of Dickkopf-1 in Preeclamptic and Normal Pregnant Women at Delivery
por: Kasoha, Mariz, et al.
Publicado: (2021) -
Let’s talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine
por: Linxweiler, Maximilian, et al.
Publicado: (2017) -
Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma
por: WEMMERT, SILKE, et al.
Publicado: (2016)